I have a feeling they will not make a market sensitive release on the asx. The shareholder communication doco release recently clearly said these kind of preclinical data will be release through conferences/peer review and on the website. Why I have no freaking idea.
- Forums
- ASX - By Stock
- KZA
- TRXE-002-1 (Cantrixil) Toxicology
TRXE-002-1 (Cantrixil) Toxicology, page-13
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)